Completed clinical trials indicate breakthrough treatment from Colhealyx. They indicate an achieved readiness up to three times faster in wound bed vascularisation and autograft readiness. Another feather in the cap.
New Avita announcement states breakthrough treatment from completed trials
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.34 |
Change
0.010(0.75%) |
Mkt cap ! $121.4M | |||
| Open | High | Low | Value | Volume |
| $1.34 | $1.37 | $1.34 | $885.1K | 655.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 26617 | $1.34 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.35 | 150 | 1 |
View Market Depth
| Last trade - 16.10pm 05/09/2025 (20 minute delay) ? |
| AVH (ASX) Chart |